Status:

COMPLETED

Study on the Association Between Vitamin C Deficiency and Diarrhea in Children

Lead Sponsor:

Institut Pasteur

Collaborating Sponsors:

Institut Cochin

University of Copenhagen

Conditions:

Diarrhea

Infantile

Eligibility:

All Genders

2-5 years

Brief Summary

Diarrheal disease is the second leading cause of death in children under five, althought it is both preventable and treatable. The causative factors of diarrheal diseases vary a lot from region to reg...

Detailed Description

Diarrheal disease is the second leading cause of death in children under five, althought it is both preventable and treatable. The causative factors of diarrheal diseases vary a lot from region to reg...

Eligibility Criteria

Inclusion

  • Controls :
  • Inclusion Criteria:
  • not suffering of diarrhea
  • no fever
  • no sign of infection
  • Exclusion criteria :
  • Suspected or diagnosed infectious diseases
  • Known genetic diseases
  • Known diseases that may interfere with iron and/or vitamin C metabolism
  • Known inflammatory diseases
  • Malnutrition
  • Diarrhea
  • Fever
  • Positive malaria rapid diagnostic test (Africa)
  • Chronic diarrhea cases :
  • Inclusion Criteria:
  • Children suffering from chronic diarrhea defined by the emission of at least 3 soft or liquid stools per day for at least 4 weeks.
  • Exclusion criteria :
  • Suspected or diagnosed infectious diseases
  • Known genetic diseases
  • Known diseases that may interfere with iron and/or vitamin C metabolism
  • Known inflammatory diseases
  • Positive malaria rapid diagnostic test (Africa)
  • Antibiotic treatment prescribed within 10 days prior to sampling
  • Nutritional supplements in the three months prior to sampling
  • Vitamin C supplementation in the last 3 months prior to blood collection
  • Acute diarrhea cases :
  • Inclusion Criteria:
  • Children suffering from acute diarrhea defined as 3 or more loose or watery stools per day for at least 3 consecutive days and up to 10 consecutive days.
  • Exclusion criteria :
  • Malnutrition
  • Suspected or diagnosed infectious diseases
  • Known genetic diseases
  • Known diseases that may interfere with iron and/or vitamin C metabolism
  • Known inflammatory diseases
  • Positive malaria rapid diagnostic test (Africa)
  • Antibiotic treatment prescribed within 10 days prior to sampling
  • Nutritional supplements in the three months prior to sampling
  • Vitamin C supplementation in the last 3 months prior to blood collection

Exclusion

    Key Trial Info

    Start Date :

    April 25 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 31 2024

    Estimated Enrollment :

    288 Patients enrolled

    Trial Details

    Trial ID

    NCT05328037

    Start Date

    April 25 2022

    End Date

    March 31 2024

    Last Update

    May 1 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Complexe Pédiatrique

    Bangui, Central African Republic

    2

    Hopital Necker

    Paris, France, 75015

    3

    Centre Hospitalier Territorial Gaston Bourret

    Noumea, New Caledonia